Geometrical prediction model for late rectal bleeding in radiotherapy of prostate cancer
References
- Brenner DJ, Hall EJ. Fractionation and protraction for radiotherapy of prostate carcinoma. International Journal of Radiation Oncology*Biology*Physics. 1999;43(5):1095-1101. doi:10.1016/s0360-3016(98)00438-6
- Yan M, Gouveia AG, Cury FL, et al. Practical considerations for prostate hypofractionation in the developing world. Nat Rev Urol. 2021;18(11):669-685. doi:10.1038/s41585-021-00498-6
- Syndikus I, Griffin C, Philipps L, et al. 10-Year efficacy and co-morbidity outcomes of a phase III randomised trial of conventional vs. hypofractionated high dose intensity modulated radiotherapy for prostate cancer (CHHiP; CRUK/06/016). JCO. 2023;41(6_suppl):304-304. doi:10.1200/jco.2023.41.6_suppl.304
- van As N, Griffin C, Tree A, et al. Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer. N Engl J Med. 2024;391(15):1413-1425. doi:10.1056/nejmoa2403365
- Cicchetti A, Fiorino C, Ebert MA, et al. Validation of prediction models for radiation-induced late rectal bleeding: Evidence from a large pooled population of prostate cancer patients. Radiotherapy and Oncology. 2023;183:109628. doi:10.1016/j.radonc.2023.109628
- Michalski JM, Gay H, Jackson A, Tucker SL, Deasy JO. Radiation Dose–Volume Effects in Radiation-Induced Rectal Injury. International Journal of Radiation Oncology*Biology*Physics. 2010;76(3):S123-S129. doi:10.1016/j.ijrobp.2009.03.078
- Salembier C, Villeirs G, De Bari B, et al. ESTRO ACROP consensus guideline on CT- and MRI-based target volume delineation for primary radiation therapy of localized prostate cancer. Radiotherapy and Oncology. 2018;127(1):49-61. doi:10.1016/j.radonc.2018.01.014
- Akimoto T, Muramatsu H, Takahashi M, et al. Rectal bleeding after hypofractionated radiotherapy for prostate cancer: Correlation between clinical and dosimetric parameters and the incidence of grade 2 or worse rectal bleeding. International Journal of Radiation Oncology*Biology*Physics. 2004;60(4):1033-1039. doi:10.1016/j.ijrobp.2004.07.695
- Bae BK, Kim JE, Pyo H, Hong SN, Park W. Long-term findings of rectal endoscopy and rectal bleeding after moderately hypofractionated, intensitymodulated radiotherapy for prostate cancer. Sci Rep. 2023;13(1). doi:10.1038/s41598-023-43202-x
- Laterza L, Cecinato P, Guido A, Mussetto A, Fuccio L. Management of Radiation-Induced Rectal Bleeding. Curr Gastroenterol Rep. 2013;15(11). doi:10.1007/s11894-013-0355-z
- Peeters STH, Heemsbergen WD, van Putten WLJ, et al. Acute and late complications after radiotherapy for prostate cancer: Results of a multicenter randomized trial comparing 68 Gy to 78 Gy. International Journal of Radiation Oncology*Biology*Physics. 2005;61(4):1019-1034. doi:10.1016/j. ijrobp.2004.07.715
- Stewart FA, Soranson JA, Alpen EL, Williams MV, Denekamp J. Radiation-Induced Renal Damage: The Effects of Hyperfractionation. Radiation Research. 1984;98(2):407. doi:10.2307/3576248
- Huang EH, Pollack A, Levy L, et al. Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer. International Journal of Radiation Oncology*Biology*Physics. 2002;54(5):1314-1321. doi:10.1016/s0360-3016(02)03742-2
- Cambria R, Jereczek-Fossa BA, Cattani F, et al. Evaluation of late rectal toxicity after conformal radiotherapy for prostate cancer. Strahlenther Onkol. 2009;185(6):384-389. doi:10.1007/s00066-009-1933-8
- Jongen CAM, Heijmen BJM, Schillemans W, et al. Normal tissue complication probability modeling for late rectal bleeding after conventional or hypofractionated radiotherapy for prostate cancer. Clinical and Translational Radiation Oncology. 2025;50:100886. doi:10.1016/j.ctro.2024.100886
- Kim TG, Park B, Song YG, et al. Patient-related risk factors for late rectal bleeding after hypofractionated radiotherapy for localized prostate cancer: a single-center retrospective study. Radiat Oncol. 2022;17(1). doi:10.1186/s13014-022-01998-4
- Brand DH, Bruningk SC, Wilkins A, et al. Estimates of Alpha/Beta (α/β) Ratios for Individual Late Rectal Toxicity Endpoints: An Analysis of the CHHiP Trial. International Journal of Radiation Oncology*Biology*Physics. 2021;110(2):596-608. doi:10.1016/j.ijrobp.2020.12.041
- Munbodh R, Jackson A, Bauer J, Schmidtlein CR, Zelefsky MJ. Dosimetric and anatomic indicators of late rectal toxicity after high‐dose intensity modulated radiation therapy for prostate cancer. Medical Physics. 2008;35(5):2137-2150. doi:10.1118/1.2907707
- Lee R, Chan EK, Kosztyla R, Liu M, Moiseenko V. Dose-distance metric that predicts late rectal bleeding in patients receiving radical prostate externalbeam radiotherapy. Phys Med Biol. 2012;57(24):8297-8307. doi:10.1088/0031-9155/57/24/8297
- Brenner DJ. Fractionation and late rectal toxicity. International Journal of Radiation Oncology*Biology*Physics. 2004;60(4):1013-1015. doi:10.1016/j.ijrobp.2004.04.014
- Dasu A, Toma-Dasu I. Prostate alpha/beta revisited – an analysis of clinical results from 14 168 patients. Acta Oncologica. 2012;51(8):963-974. doi:10.3109/0284186x.2012.719635
- Daşu A. Is the α/β Value for Prostate Tumours Low Enough to be Safely Used in Clinical Trials? Clinical Oncology. 2007;19(5):289-301. doi:10.1016/j.clon.2007.02.007
- Cui M, Gao XS, Li X, Ma M, Qi X, Shibamoto Y. Variability of α/β ratios for prostate cancer with the fractionation schedule: caution against using the linear-quadratic model for hypofractionated radiotherapy. Radiat Oncol. 2022;17(1). doi:10.1186/s13014-022-02010-9
- Drean G, Acosta O, Ospina JD, et al. Identification of a rectal subregion highly predictive of rectal bleeding in prostate cancer IMRT. Radiotherapy and Oncology. 2016;119(3):388-397. doi:10.1016/j.radonc.2016.04.023
Language: English
Page range: 72 - 78
Submitted on: Aug 25, 2025
Accepted on: Apr 1, 2026
Published on: Jun 2, 2026
Published by: Polish Society of Medical Physics
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2026 Michał Posiewnik, Paweł Czajkowsk, Dominik Małecki, published by Polish Society of Medical Physics
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.